Drug profile · INN
afatinib dimaleate
GILOTRIF
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
afatinib dimaleate (GILOTRIF) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN afatinib dimaleate
Brand GILOTRIF
Route ORAL
Formulation TABLET
Frequently asked questions
What is afatinib dimaleate?
afatinib dimaleate (GILOTRIF) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for afatinib dimaleate?
GILOTRIF is a marketed brand name for afatinib dimaleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of afatinib dimaleate?
afatinib dimaleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.